| Literature DB >> 35233238 |
Yagiz Yedekci1, Melis Gültekin1, Sezin Yuce Sarı1, Ferah Yıldız1.
Abstract
PURPOSE: To investigate the effectiveness of deformable image registration (DIR)-based automatic contouring for tandem-ring (T-R) or tandem-ovoid (T-O) 3-dimensional computed tomography (CT)-based image-guided brachytherapy (IGBT).Entities:
Keywords: brachytherapy; cervical cancer; deformable image registration; image-guided brachytherapy
Year: 2022 PMID: 35233238 PMCID: PMC8867230 DOI: 10.5114/jcb.2022.112814
Source DB: PubMed Journal: J Contemp Brachytherapy ISSN: 2081-2841
Minimum acceptance criteria for total radiotherapy plans (external beam plus brachytherapy)
| Structure | Acceptance criteria |
|---|---|
| HR-CTV | D90 > 80 Gy EQD2 |
| IR-CTV | D98 > 60 Gy EQD2 |
| Rectum | D2cc < 75 Gy EQD2 |
| Bladder | D2cc < 90 Gy EQD2 |
| Sigmoid | D2cc < 75 Gy EQD2 |
| Small bowel | D2cc < 75 Gy EQD2 |
HR-CTV – high-risk clinical target volume; IR-CTV – intermediate-risk clinical target volume; D90 – minimum dose delivered to 90% of volume; D98 – minimum dose delivered to 98% of volume; D2cc – minimum dose received by 2 cc of maximal dose regions; EQD2 – equivalent dose at 2 Gy fractions
Mean volumes of manually- and automatically-propagated contours for tandem-ovoid and tandem-ring insertions
| Volume (cc) ± SD | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HR-CTV | IR-CTV | Rectum | Bladder | Sigmoid | Small bowel | ||||||||
| Tandem-ring | |||||||||||||
| Manual | 25 ±8 | 0.64 | 57 ±11 | 0.71 | 52 ±12 | 0.74 | 92 ±85 | 0.93 | 34 ±20 | 0.18 | 387 ±151 | 0.03 | |
| Automatic | 33 ±13 | 72 ±22 | 51 ±15 | 93 ±87 | 29 ±12 | 453 ±183 | |||||||
| Tandem-ovoid | |||||||||||||
| Manual | 26 ±8 | 0.13 | 72 ±21 | 0.12 | 48 ±18 | 0.89 | 101 ±84 | 0.89 | 38 ±16 | 0.41 | 284 ±227 | 0.005 | |
| Automatic | 29 ±10 | 79 ±21 | 49 ±15 | 103 ±83 | 35 ±16 | 417 ±164 | |||||||
SD – standard deviation; HR-CTV – high-risk clinical target volume; IR-CTV – intermediate-risk clinical target volume
Fig. 1Rigid and deformable image registration for two patients who underwent tandem-ring (A) and tandem-ovoid (B) in- sertion. Manually- and automatically-propagated contours are presented for HR-CTV, IR-CTV, the rectum, bladder, sigmoid, and small bowel
Fig. 2Organs at risk volumes defined manually or automatically before and after deformable image registration
Mean and median values of dice similarity coefficients for comparison of manually- and automatically- propagated contours of target volumes and organs at risk
| DSC | DSC | ||||||
|---|---|---|---|---|---|---|---|
| Structure | Mean ±SD | Median | Structure | Mean ±SD | Median | ||
| T-R | HR-CTV | 0.83 ±0.12 | 0.84 | T-O | HR-CTV | 0.84 ±0.10 | 0.88 |
| IR-CTV | 0.81 ±0.11 | 0.82 | IR-CTV | 0.86 ±0.08 | 0.86 | ||
| Rectum | 0.81 ±0.34 | 0.74 | Rectum | 0.58 ±0.05 | 0.62 | ||
| Bladder | 0.84 ±0.16 | 0.91 | Bladder | 0.94 ±0.11 | 0.95 | ||
| Sigmoid | 0.37 ±0.07 | 0.35 | Sigmoid | 0.41 ±0.10 | 0.44 | ||
| Small bowel | 0.64 ±0.20 | 0.64 | Small bowel | 0.56 ±0.09 | 0.55 | ||
DSC – dice similarity coefficient; SD – standard deviation; T-R – tandem-ring; T-O – tandem-ovoid; HR-CTV – high-risk clinical target volume; IR-CTV – intermediate-risk clinical target volume
Target and organ at risk (OAR) doses in EQD2 for manual and automatic contouring
| Tandem-ring | Tandem-ovoid | |||||
|---|---|---|---|---|---|---|
| Manual contouring | Automatic contouring | Manual contouring | Automatic contouring | |||
| HR-CTV D90% | 90.4 ±1.1 | 89.2 ±0.9 | 0.63 | 89.6 ±0.8 | 89.1 ±0.5 | 0.54 |
| HR-CTV D98% | 73.6 ±2.2 | 69.3 ±4.4 | < 0.05 | 75.1 ±2.9 | 70.5 ±3.7 | < 0.05 |
| IR-CTV D98% | 65.7 ±1.8 | 65.2 ±2.2 | 0.92 | 65.6 ±1.4 | 65.4 ±0.7 | 0.78 |
| Rectum D2cc | 71.4 ±2.6 | 72.8 ±2.0 | 0.88 | 73.1 ±1.1 | 73.2 ±1.5 | 0.71 |
| Bladder D2cc | 78.4 ±2.1 | 78.5 ±2.1 | 0.82 | 78.9 ±0.8 | 78.9 ±0.7 | 0.75 |
| Sigmoid D2cc | 58.2 ±7.5 | 59.5 ±7.8 | 0.88 | 60.3 ±4.5 | 60.6 ±5.1 | 0.85 |
| Small bowel D2cc | 64.6 ±3.6 | 62.1 ±4.3 | 0.61 | 64.7 ±3.4 | 61.7 ±5.4 | 0.83 |
EQD2 – equivalent dose at 2 Gy fractions; SD – standard deviation; HR-CTV – high-risk clinical target volume; IR-CTV – intermediate-risk clinical target volume; D90 – minimum dose delivered to 90% of volume; D98 – minimum dose delivered to 98% of volume; D2cc – minimum dose received by 2 cc of maximal dose regions of volume